Empowered Funds
TMCI icon

Empowered Funds’s Treace Medical Concepts TMCI Stock Holding History

Empowered Funds’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$328K Buy
+73,912
New +$331K ﹤0.01% 2001

Other funds holding TMCI

Gagnon Securities
Gagnon Securities New York $577M AUM 61.61% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
GA
Gagnon Advisors New York $182M AUM 52.04% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
CIBC Bancorp USA
CIBC Bancorp USA Chicago, Illinois $79.9B AUM
Weber Capital Management
Weber Capital Management San Francisco, California $110M AUM 43.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $121B AUM 21.47% 1-Year Est. Return

Empowered Funds's TMCI Position: Q3 2026 in Review

Empowered Funds opened a new position in Treace Medical Concepts (TMCI) in Q3 2026: 73,912 shares worth $328K. The stake represents ﹤0.01% of the portfolio and ranks #2001 among its holdings.

86 funds tracked by Wall St. Rank hold TMCI as of Q3 2026.

  • Empowered Funds held 73,912 shares of Treace Medical Concepts worth $328K as of Q3 2026.
  • Treace Medical Concepts was a new Empowered Funds position in Q3 2026.
  • Treace Medical Concepts made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2001 holding.
  • 86 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.